Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sejvar, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sejvar, J. J.
Related Collections
Right arrow Viral infections
Right arrow Amyotrophic lateral sclerosis
NEUROLOGY 2004;63:206-207
© 2004 American Academy of Neurology
Views & Reviews

West Nile virus and "poliomyelitis"

James J. Sejvar, MD

From the Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta GA.

Address correspondence and reprint requests to Dr. James J. Sejvar, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS A-39, Atlanta, GA 30333; e-mail: zea3{at}cdc.gov

West Nile virus (WNV) has recently been associated with a syndrome of acute flaccid paralysis. Most cases of WNV-associated weakness have clinical, histopathologic, and electrophysiologic characteristics indistinguishable from those of poliomyelitis caused by infection with poliovirus. There is debate about the nomenclature of this manifestation of WNV infection. An historical perspective of the term "poliomyelitis" suggests that the term "WNV poliomyelitis" seems appropriate, but members of the neurologic and infectious disease communities should engage in discussion regarding the terminology of this syndrome.

Received November 12, 2003. Accepted in final form February 27, 2004.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
A. V. Chernov, S. A. Shiryaev, A. E. Aleshin, B. I. Ratnikov, J. W. Smith, R. C. Liddington, and A. Y. Strongin
The Two-component NS2B-NS3 Proteinase Represses DNA Unwinding Activity of the West Nile Virus NS3 Helicase
J. Biol. Chem., June 20, 2008; 283(25): 17270 - 17278.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
J. J. Alexander, A. S. Lasky, and W. D. Graf
Stroke Associated With Central Nervous System Vasculitis After West Nile Virus Infection
J Child Neurol, July 1, 2006; 21(7): 623 - 625.
[Abstract] [PDF]

Home page
 BMJHome page
R. S Howard
Poliomyelitis and the postpolio syndrome
BMJ, June 4, 2005; 330(7503): 1314 - 1318.
[Full Text] [PDF]

Home page
 NeurologyHome page
J. S. Khosla, M. J. Edelman, N. Kennedy, and S. G. Reich
West Nile virus presenting as opsoclonus-myoclonus cerebellar ataxia
Neurology, March 22, 2005; 64(6): 1095 - 1095.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by AAN Enterprises, Inc.